Beijing Balance Medical Technology Co.,Ltd. (SHA:688198)
China · Delayed Price · Currency is CNY 101.21
-2.61 (-2.51%)
At close: Apr 24, 2026
SHA:688198 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 188.55 | 179.68 | 146.33 | 115.21 | 95.13 | 51.2 |
Depreciation & Amortization | 42.15 | 42.15 | 22.72 | 13.7 | 6.83 | 6.93 |
Other Amortization | 3.56 | 3.56 | 2.67 | 0.53 | 0.53 | 0.46 |
Loss (Gain) From Sale of Assets | -0 | -0 | -0 | -0.06 | -0.01 | -0.01 |
Asset Writedown & Restructuring Costs | -0.83 | -0.83 | 0.05 | 0 | 0.02 | 0.03 |
Loss (Gain) From Sale of Investments | -7.85 | -7.85 | -10.75 | -17.87 | -22.3 | -15.9 |
Provision & Write-off of Bad Debts | - | - | 2.39 | 1.46 | 1.1 | 0.81 |
Other Operating Activities | -4.2 | 2.61 | -13.68 | -5.36 | -0.03 | 0.17 |
Change in Accounts Receivable | -75.27 | -75.27 | -63.04 | -30.18 | -22.36 | -30.26 |
Change in Inventory | -15.88 | -15.88 | -17.84 | -3.42 | -9.52 | -5.61 |
Change in Accounts Payable | 72.15 | 72.15 | 39.29 | 30.82 | 14.34 | 15.96 |
Change in Other Net Operating Assets | - | - | 18.12 | 29.2 | 58.24 | 80.95 |
Operating Cash Flow | 199.86 | 197.79 | 136.23 | 141.17 | 128.85 | 76.49 |
Operating Cash Flow Growth | 28.44% | 45.19% | -3.50% | 9.56% | 68.44% | 50.69% |
Capital Expenditures | -144.6 | -136.2 | -163.26 | -128.63 | -104.83 | -72.22 |
Sale of Property, Plant & Equipment | 0.02 | 0 | 0.02 | 0.31 | 0.09 | 0.02 |
Cash Acquisitions | - | - | -10.84 | -43.28 | - | - |
Investment in Securities | -33 | -18 | -235.4 | 237.72 | -29.16 | -8.56 |
Other Investing Activities | 43.32 | -24.57 | 133.24 | 13.18 | 18.88 | 16.13 |
Investing Cash Flow | -134.26 | -178.76 | -276.23 | 79.3 | -115.02 | -64.64 |
Long-Term Debt Issued | - | 75 | - | - | - | - |
Long-Term Debt Repaid | - | - | -4.25 | -2.61 | -1.39 | - |
Net Debt Issued (Repaid) | 25 | 75 | -4.25 | -2.61 | -1.39 | - |
Issuance of Common Stock | 5.33 | 5.33 | 14.48 | 16.9 | 11.34 | 10.78 |
Common Dividends Paid | -111.38 | -110.84 | -109.26 | -67.84 | -48.22 | -19.2 |
Other Financing Activities | -3.79 | -4.68 | -0 | -0 | -0.04 | -0.87 |
Financing Cash Flow | -84.83 | -35.18 | -99.03 | -53.54 | -38.31 | -9.29 |
Foreign Exchange Rate Adjustments | -0.14 | -0.14 | 0.01 | -0 | 0 | - |
Net Cash Flow | -19.36 | -16.29 | -239.03 | 166.92 | -24.49 | 2.57 |
Free Cash Flow | 55.26 | 61.6 | -27.02 | 12.53 | 24.01 | 4.27 |
Free Cash Flow Growth | 276.24% | - | - | -47.80% | 462.20% | -90.08% |
Free Cash Flow Margin | 8.33% | 9.93% | -5.38% | 3.38% | 8.14% | 1.70% |
Free Cash Flow Per Share | 0.40 | 0.45 | -0.20 | 0.09 | 0.18 | 0.03 |
Cash Interest Paid | - | - | - | - | 0 | - |
Cash Income Tax Paid | 97.86 | 74.86 | 23.06 | 14.95 | 4.59 | 21.09 |
Levered Free Cash Flow | -285.4 | -282.95 | -83.75 | -43.52 | 2.12 | -2.35 |
Unlevered Free Cash Flow | -285.4 | -282.95 | -83.47 | -43.26 | 2.17 | -2.28 |
Change in Working Capital | -21.53 | -21.53 | -13.49 | 33.56 | 47.59 | 32.8 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.